Investments & digital assets › F8949.D.X93
F8949.D.X93 · federal · F8949 line D.X93
Delmar Pharma (acquired 2024-02-02, sold 2025-12-31; proceeds 291.82, basis 344.13, adjustment W 52.31)
0
engine v3
not yet verified
How this number was built
R-8949-LOT One line per sale: proceeds minus basis plus adjustment. Broker basis is used as reported unless a supplemental statement for the same lot is matched.
Sources (6) — where the inputs came from
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_desc · “Lot X93 description”
read as “Delmar Pharma” → Delmar Pharma
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_acq · “Lot X93 date acquired”
read as “02/02/2024” → 2024-02-02
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_sold · “Lot X93 date sold”
read as “12/31/2025” → 2025-12-31
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_proceeds · “Lot X93 proceeds”
read as “291.82” → 291.82
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_basis · “Lot X93 cost basis”
read as “344.13” → 344.13
99%
Brightpath Advisors 2025 Form 1099-B (direct-indexing account)
D74 · page 27 · field X93_wash · “Lot X93 wash sale loss disallowed”
read as “52.31” → 52.31
99%
Flows into
History — nothing is overwritten
v1 · 2026-03-04: 0v2 · 2026-03-19: 0v3 · 2026-06-23: 0
Adjust this number
Evidence & discussion
Record how you verified it